{"id":"https://openalex.org/W4393085488","doi":"https://doi.org/10.1158/1538-7445.am2024-5870","title":"Abstract 5870: Taxane-based chemotherapy leads to acquired resistance through ecDNA-based amplification of multi-drug resistance genes","display_name":"Abstract 5870: Taxane-based chemotherapy leads to acquired resistance through ecDNA-based amplification of multi-drug resistance genes","publication_year":2024,"publication_date":"2024-03-22","ids":{"openalex":"https://openalex.org/W4393085488","doi":"https://doi.org/10.1158/1538-7445.am2024-5870"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.am2024-5870","doi":"https://doi.org/10.1158/1538-7445.am2024-5870","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2024-5870","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5003758278","display_name":"Kristen M. Holmes","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210091888","display_name":"Boundless Bio (United States)","ror":"https://ror.org/00ck5k311","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091888"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kristen Holmes","raw_affiliation_strings":["1Boundless Bio, Inc., San Diego, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Boundless Bio, Inc., San Diego, CA","institution_ids":["https://openalex.org/I4210091888"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076015552","display_name":"Dean Perusse","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210091888","display_name":"Boundless Bio (United States)","ror":"https://ror.org/00ck5k311","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091888"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Dean Perusse","raw_affiliation_strings":["1Boundless Bio, Inc., San Diego, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Boundless Bio, Inc., San Diego, CA","institution_ids":["https://openalex.org/I4210091888"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004685741","display_name":"Cory D. DuPai","orcid":"https://orcid.org/0000-0002-7915-9473","observed_orcids":["https://orcid.org/0000-0002-7915-9473"]},"institutions":[{"id":"https://openalex.org/I4210091888","display_name":"Boundless Bio (United States)","ror":"https://ror.org/00ck5k311","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091888"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Cory DuPai","raw_affiliation_strings":["1Boundless Bio, Inc., San Diego, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Boundless Bio, Inc., San Diego, CA","institution_ids":["https://openalex.org/I4210091888"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046416849","display_name":"Homa Hemmati","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210091888","display_name":"Boundless Bio (United States)","ror":"https://ror.org/00ck5k311","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091888"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Homa Hemmati","raw_affiliation_strings":["1Boundless Bio, Inc., San Diego, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Boundless Bio, Inc., San Diego, CA","institution_ids":["https://openalex.org/I4210091888"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Julie Weiss","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210091888","display_name":"Boundless Bio (United States)","ror":"https://ror.org/00ck5k311","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091888"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Julie Weiss","raw_affiliation_strings":["1Boundless Bio, Inc., San Diego, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Boundless Bio, Inc., San Diego, CA","institution_ids":["https://openalex.org/I4210091888"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068222224","display_name":"Claire Kuelbs","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210091888","display_name":"Boundless Bio (United States)","ror":"https://ror.org/00ck5k311","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091888"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Claire Kuelbs","raw_affiliation_strings":["1Boundless Bio, Inc., San Diego, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Boundless Bio, Inc., San Diego, CA","institution_ids":["https://openalex.org/I4210091888"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5093395289","display_name":"John Bibay","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210091888","display_name":"Boundless Bio (United States)","ror":"https://ror.org/00ck5k311","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091888"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"John Bibay","raw_affiliation_strings":["1Boundless Bio, Inc., San Diego, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Boundless Bio, Inc., San Diego, CA","institution_ids":["https://openalex.org/I4210091888"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101888155","display_name":"Joan W. Chen","orcid":"https://orcid.org/0000-0002-1042-6932","observed_orcids":["https://orcid.org/0000-0002-1042-6932"]},"institutions":[{"id":"https://openalex.org/I4210091888","display_name":"Boundless Bio (United States)","ror":"https://ror.org/00ck5k311","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091888"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Joan Chen","raw_affiliation_strings":["1Boundless Bio, Inc., San Diego, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Boundless Bio, Inc., San Diego, CA","institution_ids":["https://openalex.org/I4210091888"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110647008","display_name":"Debbie Liao","orcid":"https://orcid.org/0009-0006-0019-0133","observed_orcids":["https://orcid.org/0009-0006-0019-0133"]},"institutions":[{"id":"https://openalex.org/I4210091888","display_name":"Boundless Bio (United States)","ror":"https://ror.org/00ck5k311","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091888"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Debbie Liao","raw_affiliation_strings":["1Boundless Bio, Inc., San Diego, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Boundless Bio, Inc., San Diego, CA","institution_ids":["https://openalex.org/I4210091888"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031762628","display_name":"Christian A. Hassig","orcid":"https://orcid.org/0009-0005-7431-9166","observed_orcids":["https://orcid.org/0009-0005-7431-9166"]},"institutions":[{"id":"https://openalex.org/I4210091888","display_name":"Boundless Bio (United States)","ror":"https://ror.org/00ck5k311","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091888"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Christian Hassig","raw_affiliation_strings":["1Boundless Bio, Inc., San Diego, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Boundless Bio, Inc., San Diego, CA","institution_ids":["https://openalex.org/I4210091888"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5081003431","display_name":"Shailaja Kasibhatla","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210091888","display_name":"Boundless Bio (United States)","ror":"https://ror.org/00ck5k311","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091888"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Shailaja Kasibhatla","raw_affiliation_strings":["1Boundless Bio, Inc., San Diego, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Boundless Bio, Inc., San Diego, CA","institution_ids":["https://openalex.org/I4210091888"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I4210091888"],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":2,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"84","issue":"6_Supplement","first_page":"5870","last_page":"5870"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10570","display_name":"Drug Transport and Resistance Mechanisms","score":0.9940999746322632,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10570","display_name":"Drug Transport and Resistance Mechanisms","score":0.9940999746322632,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10147","display_name":"Antibiotic Resistance in Bacteria","score":0.0010000000474974513,"subfield":{"id":"https://openalex.org/subfields/2726","display_name":"Microbiology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11752","display_name":"Cancer Treatment and Pharmacology","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/extrachromosomal-dna","display_name":"extrachromosomal DNA","score":0.9049999713897705},{"id":"https://openalex.org/keywords/paclitaxel-resistance","display_name":"paclitaxel resistance","score":0.8479999899864197},{"id":"https://openalex.org/keywords/taxane-based-chemotherapy","display_name":"taxane-based chemotherapy","score":0.8450000286102295},{"id":"https://openalex.org/keywords/p-glycoprotein","display_name":"P-glycoprotein","score":0.9739999771118164},{"id":"https://openalex.org/keywords/multidrug-resistance","display_name":"multidrug resistance","score":0.8309999704360962},{"id":"https://openalex.org/keywords/myc-amplification","display_name":"MYC amplification","score":0.6800000071525574},{"id":"https://openalex.org/keywords/fgfr2-amplification","display_name":"FGFR2 amplification","score":0.9629999995231628},{"id":"https://openalex.org/keywords/erbb2-amplification","display_name":"ERBB2 amplification","score":0.9860000014305115},{"id":"https://openalex.org/keywords/focal-amplification","display_name":"focal amplification","score":0.453000009059906},{"id":"https://openalex.org/keywords/oncogene-amplification","display_name":"oncogene amplification","score":0.6420000195503235},{"id":"https://openalex.org/keywords/tumor-genomic-heterogeneity","display_name":"tumor genomic heterogeneity","score":0.49000000953674316}],"concepts":[{"id":"https://openalex.org/C2777511904","wikidata":"https://www.wikidata.org/wiki/Q425227","display_name":"Taxane","level":4,"score":0.8901103734970093},{"id":"https://openalex.org/C114851261","wikidata":"https://www.wikidata.org/wiki/Q12147416","display_name":"Drug resistance","level":2,"score":0.5720598697662354},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.5387319922447205},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.43789276480674744},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.43111586570739746},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.4080542325973511},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.39474380016326904},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.37755119800567627},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3068385124206543},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.29951244592666626},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.23251008987426758},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.19972118735313416},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.06280094385147095}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.am2024-5870","doi":"https://doi.org/10.1158/1538-7445.am2024-5870","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2024-5870","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9391000270843506,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W7148645501","https://openalex.org/W4393086642","https://openalex.org/W6958637627","https://openalex.org/W3182054098","https://openalex.org/W4378832443","https://openalex.org/W2767031674","https://openalex.org/W2164833579","https://openalex.org/W6977244101","https://openalex.org/W4389227584","https://openalex.org/W3108916724"],"abstract_inverted_index":{"Abstract":[0],"Focal":[1],"amplification":[2,41,96,168,187,198,208,274,414],"on":[3,134,154,188],"extrachromosomal":[4],"DNA":[5],"(ecDNA)":[6],"drives":[7,101],"high":[8],"gene":[9,40],"copy":[10,220,230],"number":[11,221],"and":[12,21,34,122,124,130,141,144,148,151,184,223,256,269,299,324,351],"intercellular":[13,219],"genomic":[14],"heterogeneity,":[15],"which":[16,171],"can":[17,294],"fuel":[18],"tumor":[19,98],"adaptation":[20],"drug":[22,236,282],"resistance.":[23,302],"Targeted":[24],"therapies":[25,61,305,362],"have":[26,42,306,321,377],"largely":[27],"failed":[28],"in":[29,97,240,254,267,296,333,347,358],"patients":[30,35,48,63,69,311,318,326],"with":[31,64,162,284,312],"oncogene":[32,65],"amplification,":[33],"whose":[36,49],"tumors":[37],"harbor":[38,51],"ecDNA-based":[39,211,341,413],"particularly":[43],"worse":[44],"survival":[45],"compared":[46],"to":[47,56,87,105,108,278,343,356,409],"cancers":[50],"other":[52,88],"genetic":[53],"drivers.":[54],"Due":[55],"the":[57,163,423],"lack":[58],"of":[59,90,169,207,216,228,247,250,260,281,336,415,422],"approved":[60],"for":[62,115,310,370,426],"amplified":[66,125,133,146,153,242],"cancers,":[67],"many":[68,378],"receive":[70,328],"chemotherapy;":[71],"however,":[72],"resistance":[73,107,178,237,251,342,355,411,417],"often":[74],"develops":[75],"through":[76,412],"mechanisms":[77],"such":[78],"as":[79],"ATP-binding":[80],"cassette":[81],"(ABC)":[82],"transporter":[83,103],"overexpression,":[84],"rendering":[85],"cross-resistance":[86],"forms":[89],"chemotherapy.":[91],"We":[92,118,232,338],"examined":[93],"whether":[94,235],"ecDNA":[95,135,262],"cell":[99,126,157,192,243,349],"lines":[100,158,244,350],"ABC":[102],"overexpression":[104],"mediate":[106],"paclitaxel,":[109],"a":[110,175,200,204],"commonly":[111],"prescribed":[112],"taxane":[113],"chemotherapy":[114,329,357,407],"cancer":[116,317,348],"patients.":[117,359],"selected":[119],"non-amplified":[120,191],"(DLD1":[121],"SW48)":[123],"lines,":[127],"including":[128,218],"COLO320DM":[129,255],"COLO320HSR":[131,257],"(MYC":[132],"or":[136],"chromosomal":[137],"loci,":[138],"respectively);":[139],"SNU16":[140,268],"H716,":[142],"(FGFR2":[143],"MYC":[145,152,288],"ecDNA);":[147],"H2170":[149,270],"(ERBB2":[150],"ecDNA).":[155],"All":[156],"developed":[159],"paclitaxel":[160,224,301,344],"resistance,":[161],"majority":[164],"(5/7)":[165],"gaining":[166],"focal":[167,196],"ABCB1,":[170],"encodes":[172],"P-glycoprotein":[173],"(P-gp),":[174],"common":[176,346],"multi-drug":[177,416],"transporter.":[179],"Four":[180],"models\u2013COLO320DM,":[181],"COLO320HSR,":[182],"SNU16,":[183],"H2170\u2014developed":[185],"ABCB1":[186,197,212,229,241,261,273],"ecDNA;":[189],"one":[190],"line":[193],"(DLD1)":[194],"acquired":[195,410],"via":[199,258],"breakage-fusion-bridge":[201],"(BFB)":[202],"mechanism,":[203],"distinct":[205],"form":[206],"from":[209],"ecDNA.":[210],"amplifications":[213],"exhibited":[214],"hallmarks":[215],"ecDNA,":[217,289],"heterogeneity":[222],"dose-dependent":[225],"rapid":[226],"evolution":[227],"number.":[231],"next":[233],"assessed":[234],"was":[238,252,275],"reversible":[239],"following":[245],"removal":[246],"paclitaxel.":[248],"Reversal":[249],"observed":[253],"loss":[259],"within":[263],"4-6":[264],"weeks.":[265],"However,":[266],"resistant":[271],"cells,":[272],"retained":[276],"up":[277],"12":[279],"weeks":[280],"removal,":[283],"apparent":[285],"integration":[286],"into":[287],"demonstrating":[290],"that":[291,340],"ecDNA-enabled":[292],"plasticity":[293],"result":[295],"both":[297],"short-":[298],"long-term":[300],"Although":[303],"targeted":[304],"revolutionized":[307],"treatment":[308,368],"approaches":[309],"actionable":[313,322],"oncodriver":[314],"alterations,":[315],"most":[316,325],"do":[319,375],"not":[320,376],"drivers":[323],"still":[327],"at":[330],"some":[331],"point":[332],"their":[334],"course":[335],"treatment.":[337],"demonstrated":[339],"is":[345],"may":[352,364],"also":[353],"drive":[354],"Thus,":[360],"ecDNA-directed":[361],"(ecDTx)":[363],"be":[365],"an":[366],"important":[367],"option":[369],"chemo-resistant":[371],"patients,":[372],"who":[373],"currently":[374],"effective":[379],"therapeutic":[380],"options.":[381],"Citation":[382],"Format:":[383],"Kristen":[384],"Holmes,":[385],"Dean":[386],"Perusse,":[387],"Cory":[388],"DuPai,":[389],"Homa":[390],"Hemmati,":[391],"Julie":[392],"Weiss,":[393],"Claire":[394],"Kuelbs,":[395],"John":[396],"Bibay,":[397],"Joan":[398],"Chen,":[399],"Debbie":[400],"Liao,":[401],"Christian":[402],"Hassig,":[403],"Shailaja":[404],"Kasibhatla.":[405],"Taxane-based":[406],"leads":[408],"genes":[418],"[abstract].":[419],"In:":[420],"Proceedings":[421],"American":[424],"Association":[425],"Cancer":[427,445],"Research":[428],"Annual":[429],"Meeting":[430],"2024;":[431],"Part":[432],"1":[433],"(Regular":[434],"Abstracts);":[435],"2024":[436],"Apr":[437],"5-10;":[438],"San":[439],"Diego,":[440],"CA.":[441],"Philadelphia":[442],"(PA):":[443],"AACR;":[444],"Res":[446],"2024;84(6_Suppl):Abstract":[447],"nr":[448],"5870.":[449]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":1}],"updated_date":"2026-09-29T14:09:16.559479","created_date":"2024-03-23T00:00:00"}